Trial Profile
Combination of alpha2-adrenoreceptor agonists, opioids and ketamine for improving of perioperative course
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2023
Price :
$35
*
At a glance
- Drugs Alfentanil (Primary) ; Dexmedetomidine (Primary) ; Fentanyl (Primary) ; Pethidine
- Indications Sedation
- Focus Therapeutic Use
- 13 Aug 2023 Status changed from recruiting to completed.
- 24 Dec 2016 New trial record